DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+13.3%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$118M
AUM Growth
+$118M
Cap. Flow
-$3.17M
Cap. Flow %
-2.68%
Top 10 Hldgs %
44.84%
Holding
84
New
18
Increased
12
Reduced
22
Closed
12

Top Buys

1
LOXO
Loxo Oncology, Inc
LOXO
$6.77M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$3.99M
3
CLLS
Cellectis
CLLS
$1.83M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
$1.57M
5
BLRX
BioLineRX
BLRX
$961K

Top Sells

1
GLPG icon
Galapagos
GLPG
$2.65M
2
CYTK icon
Cytokinetics
CYTK
$2.56M
3
DERM
Dermira, Inc.
DERM
$2.41M
4
AERI
Aerie Pharmaceuticals, Inc.
AERI
$2.34M
5
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
$2.1M

Sector Composition

1 Healthcare 85.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RIGL icon
26
Rigel Pharmaceuticals
RIGL
$710M
$1.57M 1.33%
+47,348
New +$1.57M
ADXS
27
DELISTED
Advaxis, Inc.
ADXS
$1.41M 1.19%
11,467
-200
-2% -$24.5K
XENE icon
28
Xenon Pharmaceuticals
XENE
$2.99B
$1.36M 1.15%
339,614
-174,477
-34% -$698K
QURE icon
29
uniQure
QURE
$954M
$1.18M 1%
203,907
– –
JNJ icon
30
Johnson & Johnson
JNJ
$429B
$1.17M 0.99%
9,400
– –
SCYX icon
31
SCYNEXIS
SCYX
$35.2M
$1.05M 0.89%
38,190
+20,825
+120% +$575K
NDRM
32
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$994K 0.84%
37,438
-483
-1% -$12.8K
BLRX
33
BioLineRX
BLRX
$15.5M
$961K 0.81%
+1,667
New +$961K
DERM
34
DELISTED
Dermira, Inc.
DERM
$955K 0.81%
28,000
-70,800
-72% -$2.41M
VYGR icon
35
Voyager Therapeutics
VYGR
$204M
$944K 0.8%
+71,320
New +$944K
ELOS
36
DELISTED
Syneron Medical Ltd
ELOS
$907K 0.77%
85,947
– –
TNDM icon
37
Tandem Diabetes Care
TNDM
$834M
$869K 0.74%
72,429
– –
ARQL
38
DELISTED
Arqule Inc
ARQL
$855K 0.72%
807,008
+138,273
+21% +$146K
ACHN
39
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$827K 0.7%
196,500
– –
NERV icon
40
Minerva Neurosciences
NERV
$16.8M
$821K 0.69%
+12,665
New +$821K
BLUE
41
DELISTED
bluebird bio
BLUE
$818K 0.69%
695
– –
EXAC
42
DELISTED
Exactech Inc
EXAC
$797K 0.67%
31,636
– –
STXS icon
43
Stereotaxis
STXS
$247M
$782K 0.66%
1,372,862
– –
CASC
44
DELISTED
Cascadian Therapeutics, Inc.
CASC
$767K 0.65%
+185,259
New +$767K
NVDQ
45
DELISTED
Novadaq Technologies Inc.
NVDQ
$747K 0.63%
95,841
-6,000
-6% -$46.8K
NEOS
46
DELISTED
Neos Therapeutics, Inc
NEOS
$686K 0.58%
95,273
+56,400
+145% +$406K
ZGNX
47
DELISTED
Zogenix, Inc.
ZGNX
$649K 0.55%
59,778
-14,760
-20% -$160K
AKBA icon
48
Akebia Therapeutics
AKBA
$827M
$648K 0.55%
+70,455
New +$648K
CGNT
49
DELISTED
Cogentix Medical, Inc.
CGNT
$636K 0.54%
353,482
– –
MTVA
50
MetaVia Inc. Common Stock
MTVA
$16.2M
$554K 0.47%
+9
New +$554K
1
2
3 4